Several countries have implemented primary human papillomavirus (HPV) testing for
cervical cancer screening. HPV testing enables home‐based, self‐collected sampling (self …

Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …

Background The effectiveness of cervical cancer screening programs is challenged by
suboptimal participation and coverage. Offering cervico-vaginal self-sampling for human …

Objective We assessed the cost-effectiveness of mailing a human papillomavirus self-
sampling (HPV-ss) kit, directly or via invitation to order, compared with mailing reminder …

RACOMIP is a population‐based, randomized trial of the effectiveness and cost‐
effectiveness of different interventions aimed at increasing participation in a well‐run …

Introduction Non-participation in screening is a main risk factor for cervical cancer. Human-
papillomavirus (HPV) self-sampling may be an alternative to repeated invitations for non …

Background: Attendance in screening is an important determinant of cervical cancer.
Previous experience on high-risk human papillomavirus (hrHPV) DNA testing on patient …

Background Many cervical cancers occur among women who have not attended cervical
screening. Strategies to reach non-attending women may improve the effectiveness of …

Background: Cervical screening on self-collected samples has mainly been considered for
targeted use in underscreened women. Updated evidence supports equivalent sensitivity of …

With the objective to investigate associations between sociodemographic characteristics
and participation in interventions designed to increase participation in cervical cancer …